Correlation Between SAB Biotherapeutics and Histogen
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Histogen, you can compare the effects of market volatilities on SAB Biotherapeutics and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Histogen.
Diversification Opportunities for SAB Biotherapeutics and Histogen
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Histogen is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Histogen go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Histogen
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 7.07 times more return on investment than Histogen. However, SAB Biotherapeutics is 7.07 times more volatile than Histogen. It trades about 0.08 of its potential returns per unit of risk. Histogen is currently generating about 0.19 per unit of risk. If you would invest 6.20 in SAB Biotherapeutics on November 3, 2024 and sell it today you would lose (2.52) from holding SAB Biotherapeutics or give up 40.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 90.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Histogen
Performance |
| Timeline |
| SAB Biotherapeutics |
| Histogen |
SAB Biotherapeutics and Histogen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Histogen
The main advantage of trading using opposite SAB Biotherapeutics and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
| Histogen vs. Virax Biolabs Group | Histogen vs. Artelo Biosciences | Histogen vs. Curis Inc | Histogen vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |